Billy Amzal, Head of Strategic Consulting at Phastar, and a Bayesian design expert and pioneer, explores the techniques used in Bayesian trial designs, examines regulatory updates, and shares real-world examples of the impact of these innovative methods in a new article for Applied Clinical Trials.
“With rare disease a growing area of clinical research and clearer expectations set by the FDA, the industry can no longer afford to wait when it comes to adopting Bayesian methods.”